Pulse Biosciences PLSE
NASDAQ PLSE
$52.68 +1.37 (+2.67%)
At close: Oct 22, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) Current Deferred Revenue (2021 - 2023)

Updated

Pulse Biosciences' Current Deferred Revenue came in at $4,000 for Q1 2023, down 75.0% from $16,000 a year earlier.

Analysis

Pulse Biosciences (PLSE) Current Deferred Revenue (2021 - 2023) Analysis & Trends

At the end of FY2021, Pulse Biosciences' Current Deferred Revenue was $16,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn
10 Pulse Biosciences 3.73 Bn 3.35 Bn 161,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 4,000.00
Sep 30, 2022 38,000.00
Jun 30, 2022 32,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 16,000.00
Sep 30, 2021 7,000.00
API Access

Pulse Biosciences Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=PLSE&period=max&api_key=YOUR_API_KEY